Home>Topics>Stocks>Perrigo Company

Perrigo Company PRGO

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Attractive tax inversion targets remain, analysts say

      Headlines

      Mon, 21 Jul 2014

      medical firms that should be high on the target acquisition list for tax inversion deals. Ireland-based Perrigo (NYSE: PRGO ), Switzerland-based Actelion and U.K.-based Smith & Nephew Plc (NYSE: SNN ) ( OTCQB:SNNUF ) are all attractive targets

    2. Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life (7/15/14)

      Headlines

      Wed, 16 Jul 2014

      like to own stocks that have FCC investigations. Now that has passed. It seems like an inexpensive stock." Perrigo (NYSE: PRGO ): "I believe the rumors that Perrigo might end up getting a bid, and I like the earnings profile from Perrigo." Rite Aid

    3. Indian drug firm initiates recall

      Headlines

      Fri, 11 Jul 2014

      the U.S. under the brand name Effexor XR. Sun is also recalling 200 vials of the chemo drug gemcitabine in the U.S. due to a lack of assurance of sterility. Related tickers: ( TEVA ) ( RDY ) ( MYL ) ( MNK ) ( PRGO ) Post your comment!

    4. Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does

      Headlines

      Fri, 20 Jun 2014

      it makes it harder for Allergan to buy Shire and get a tax inversion. Perrigo is undervalued My estimate for Perrigo Company 's ( PRGO ) earnings for the next 12 months is around $8 (see this article for details ). That means Perrigo trades

    5. Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them

      Headlines

      Wed, 11 Jun 2014

      By Uncommon Profit Investor : Introduction Perrigo Company PLC ( PRGO ) has a market cap of $18.6 billion with revenue in the latest quarter of $1 billion. Perrigo make store-brand medications

    6. From Barron’s, March 24, 2014 (Part 2)

      Commentary

      Sat, 22 Mar 2014

      pharma. His picks are AGN, ESRX, ISRG, REGN, RHHBY ; also mentioned are BIIB, GILD, PCYC, MDVN, ALPMY, ABBV, JAZZ, PRGO , ACT, JNJ, BMY, MRK, A . Pg 30: Electronic investor analyses various portfolios and concludes that a 60-40 portfolio

    7. New Morningstar Analyst Report for Perrigo Company PLC

      Stock Reports

      Thu, 6 Feb 2014

      Perrigo benefits from weak economic conditions, competitor recalls, and opportunistic acquisitions.

    8. Here's Flakey's own iteration of the total stock market index

      Commentary

      Wed, 4 Sep 2013

      cyclical/2.322% in each CHD, FHCO, JJSF and VLGEA/consumer defensive/2.55% in each ATRI, GILD, IDXX, MLAB, NVO and PRGO /healthcare/2.147% in each ATNI/communication services/3.83%; and lastly CERN, CNQR, TYL/technology/5.51

    9. These eight stocks in an equally weighted portfolio gained 1000% over the last ten years

      Commentary

      Sun, 25 Aug 2013

      basis. They're not cheap but definitely worth a buy when they rarely tank. Here they are: DORM, EXPO, GILD, IT JBHT, PRGO TSCO, and WAB. Keep an eye on them; write those broker's checks when they correct and enjoy huge low volatility, low risk

    10. Perrigo Seeks Tax Advantage Through Acquisition of Elan

      Commentary

      Mon, 29 Jul 2013

      Perrigo PRGO announced that it will acquire Elan ELN in an $8.6 billion stock and cash deal, or $6.7 billion excluding Elan’s nearly

    « Prev12345Next »
    Content Partners